Design Therapeutics Inc (DSGN)
3.30
-0.05
(-1.49%)
USD |
NASDAQ |
Jun 25, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
Design Therapeutics Cash from Investing (Quarterly): 20.62M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.62M |
| December 31, 2023 | 5.555M |
| September 30, 2023 | 15.27M |
| June 30, 2023 | 11.98M |
| March 31, 2023 | 19.73M |
| December 31, 2022 | -1.056M |
| September 30, 2022 | -63.39M |
| June 30, 2022 | -156.96M |
| March 31, 2022 | 0.414M |
| Date | Value |
|---|---|
| December 31, 2021 | -50.06M |
| September 30, 2021 | -5.042M |
| June 30, 2021 | -21.57M |
| March 31, 2021 | 23.03M |
| December 31, 2020 | 1.998M |
| September 30, 2020 | 3.187M |
| June 30, 2020 | 0.501M |
| March 31, 2020 | -39.25M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-156.96M
Minimum
Jun 2022
23.03M
Maximum
Mar 2021
-13.83M
Average
0.501M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -66.00M |
| AbbVie Inc | -9.588B |
| PTC Therapeutics Inc | -114.93M |
| Revance Therapeutics Inc | -31.71M |
| Context Therapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.44M |
| Cash from Financing (Quarterly) | 0.02M |
| Free Cash Flow | -53.94M |
| Free Cash Flow Per Share (Quarterly) | -0.2237 |
| Free Cash Flow Yield | -29.03% |